A new study published in the Journal of Affective Disorders highlights the increased risk of depression in women during the perimenopause stage of their life compared to the premenopause and postmenopause stages. The researchers analyzed seven peer-reviewed longitudinal prospective studies involving over 11,000 participants to assess the risk of developing clinical depression and depressive symptoms during different menopause stages. It was found that women in perimenopause are more vulnerable to depression, emphasizing the need for screening and support for this group.
Dr. Cielo Gnecco, an obstetrician and gynecologist, pointed out the importance of screening patients for depression during menopause. She mentioned that depression is often overlooked by healthcare providers who focus on physical symptoms like hot flashes and low libido. The study results have motivated her to incorporate depression screening into her practice to better support her patients during the menopausal transition.
The study findings are consistent with previous research showing that women with vasomotor symptoms like hot flashes are at a higher risk of developing depression during menopause. Psychosocial factors and a history of major depression also contribute to the increased risk of depression in menopausal women. Dr. Michael Krychman, an OB/GYN, highlighted the multi-faceted nature of depression during the menopausal transition, with hormonal, biological, and psychosocial factors playing a role.
The prevalence of depression during menopause highlights the need for individualized treatment approaches tailored to each woman’s unique needs. Dr. Krychman emphasized the importance of empowering women to discuss their symptoms and seek appropriate interventions. Whether hormonal, biological, or psychosocial, there are safe and effective treatments available, including hormone therapy, antidepressants, and cognitive behavioral therapy.
Depressive symptoms are more common in women than men and are more likely to occur during midlife, particularly in the perimenopause stage. Symptoms such as sadness, anxiety, fatigue, sleep disturbances, and thoughts of suicide can significantly impact a woman’s quality of life during menopause. It is crucial for healthcare providers to listen to patients, consider menopause transition in assessments, and tailor treatment plans accordingly to address the underlying causes of depression.
Overall, the study sheds light on the increased risk of depression in women during the perimenopause stage and the importance of proactively screening and providing support for these individuals. By addressing the physical, emotional, and psychological aspects of menopause, healthcare providers can help women navigate this challenging transition with effective interventions tailored to their individual needs.
